Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2023-05-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
第五届监事会第七次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dirui Medical Technology Co., Ltd. regarding the approval of matters related to the 2021 restricted stock incentive plan, including the lifting of restrictions and repurchase cancellation of certain restricted stocks. It includes voting results and references to further detailed announcements on a regulatory information website. The document is short (1207 characters) and primarily reports on board meeting decisions and approvals, not a full report or financial statement. It does not contain financial data or detailed management discussion. It is not an annual or interim report, earnings release, or audit report. It is not a proxy solicitation or voting results declaration but a board/management information announcement about supervisory board resolutions. Therefore, the best fitting category is Board/Management Information (MANG).
2023-05-09 Chinese
第五届董事会第十六次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the company's board of directors regarding decisions made in a board meeting held on May 9, 2023. It includes approval of matters related to the 2021 restricted stock incentive plan and stock repurchase and cancellation. The document contains voting results and mentions legal opinions and compliance with company law and articles of association. It does not contain financial statements or detailed financial performance data. The document is a formal announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short (1175 characters), and it is not an announcement of a report publication or a certification letter, so it is not RPA or RNS. Therefore, the best classification is MANG with high confidence.
2023-05-09 Chinese
关于第五届董事会第十六次临时会议相关事项的独立董事意见
Board/Management Information Classification · 95% confidence The document is titled as the "Independent Directors' Opinions" related to the 16th extraordinary meeting of the 5th Board of Directors of Dirui Medical Technology Co., Ltd. It discusses the independent directors' opinions on matters such as the unlocking of restricted stock incentive plans and the repurchase and cancellation of restricted stocks. The content focuses on board-level decisions and compliance with regulations regarding stock incentive plans. There is no financial data, earnings information, or report publication announcement. The document is clearly related to board/management information, specifically opinions and approvals from independent directors on board matters. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report, so it is not RPA or RNS.
2023-05-09 Chinese
关于回购注销2021年限制性股票激励计划部分激励对象已获授但尚未解除限售的限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the company's repurchase and cancellation of restricted shares under the 2021 restricted stock incentive plan. It includes specifics about the number of shares, prices, approvals by the board and shareholders, legal opinions, and the impact on share capital structure. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a formal regulatory announcement about share repurchase and cancellation activities related to stock incentives. This fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares.
2023-05-09 Chinese
2023-030 迪瑞医疗：关于持股5%以上股东及一致行动人减持股份变动达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the reduction of shareholding by shareholders holding more than 5% of the company's shares. It details the shareholding changes, the percentage of shares reduced, compliance with relevant securities laws, and includes specific shareholder names and share quantities. The document does not contain financial statements or performance data but focuses on shareholding changes and regulatory compliance related to insider share transactions. This matches the definition of a Major Shareholding Notification (MRQ), which involves notifications of changes in significant share ownership levels crossing thresholds.
2023-04-25 Chinese
关于变更医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the change of a medical device production license, including details about the license number, production address, scope, and issuing authority. It is a regulatory announcement about a license update, not a financial report, earnings release, or management information. The document is short (872 characters) and does not contain financial data or results. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-04-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.